Cassava Sciences, Inc. (SAVA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...
BioSpace takes a look at the headlines across a heavy earnings week for biotechs, checking in on Allogene, Rapport and more.
Barchart on MSN8h
A High-potential Bull Put Strategy on Cassava SciencesU.S. markets have been on a historic bull run since the end of the pandemic. However, many investors may start to be wary.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback